Skip to content
Search

Latest Stories

Reckitt Benckiser names Jeff Carr as chief financial officer

RECKITT Benckiser Group plc (RB) today (21) announced the appointment of Jeff Carr as chief financial officer (CFO) and executive director to succeed Adrian Hennah, who will be retiring next year.

Carr will join the company and the board on or before April 9, next year.


In his current role, Carr is the chief financial officer, and management board and executive committee member at Ahold Delhaize, where he has been since 2011.

Hennah will be stepping down as chief financial officer and executive director when Carr starts, remaining with the company until his retirement date of October 21, 2020, to ensure a seamless transition.

Laxman Narasimhan, chief executive officer, RB, commented: “We are pleased to have appointed Jeff as chief financial officer. Jeff [Carr] brings extensive experience across consumer and retail companies and is also an alumnus of RB…

Carr commented :“I spent part of my early career at RB and I am delighted to re-join RB as its CFO. I have always valued the business’s entrepreneurial energy and creativity and, like Laxman, see great potential to drive positive change. I look forward to starting in the role next year.”

As CFO of Reckitt Benckiser Group, Jeff will receive a salary of £680,000.

The share ownership requirement will be 100,000 shares, and there will be a formal post-employment shareholding requirement, for two years after departure.

As Carr is moving from the Netherlands to the UK, he is eligible for relocation benefits.

Carr began his career at Unilever as a graduate trainee and has held senior roles at Grand Metropolitan, Associated British Foods, easyJet and First Group, and senior finance roles in RB between 1994-2004.

Jeff also serves as non-executive director of Kingfisher.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less